J4 ›› 2013, Vol. 12 ›› Issue (12): 39-42.
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract:
Objective: To understand the distribution of causative organisms in urinary tract infection and drug resistance of Escherichia coli in a hospital located in Baoshan in order to provide clinicians the basis for rational use of antibiotics. Methods:The identification of bacteria and susceptibility test were performed by using automatic bioanalysis- VITET-2 Compact 60 and Kirby-Bauer methods; the detection rate and the drug sensitivity results of bacterial were analyzed statistically. Results: The first three detection rates of causative bacteria in urine samples were: Escherichia coli topped (74.2%), Klebsiella pneumoniae followed(10%), Staphylococcus epidermidis was third (4.3%). The detection rates of causative bacteria in the top three clinical departments were: department of urology 45.7%, department of rehabilitation 20%, ICU 14.3%. The top three drug resistance rates of 52 strains of Escherichia coli to 13 kinds of antibiotics were: ampicillin 98%, cotrimoxazole 76.9%, gentamicin 65.4%. All the strains of Escherichia coli were sensitive to ertapenem and imipenem; 29 cases of ESBL-producing Escherichia coli accounted for 55.8%, 23 cases of non ESBL-producing ones accounted for 44.2%. Conclusion: Escherichia coli are in the majority of urinary tract infections caused by organisms in hospital. The infectious cases in urinary department are first in the distribution of clinical departments. Since the drug resistance of Escherichia coli in urinary tract infection is serious, the hospital should strengthen monitoring of drug resistance of Escherichia coli and doctors should select antibiotics based on the results of drug sensitivity test in vitro.
Key words: urinary tract infection, Escherichia coli, ESBLS, drug resistance of bacteria
CLC Number:
R691.3
SONG Jing-Jing, ZHANG Qun-Zhi. The Distribution of Causative Bacteria and Drug Resistance of Escherichia Coli in Urinary Tract Infection[J]. J4, 2013, 12(12): 39-42.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/
http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/Y2013/V12/I12/39
〔1〕宁立芬,汪玉珍,谢彬,等.泌尿系感染的病原菌分布及耐 药性调查〔J〕.中华医院感染学杂志,2009,19(3):351- 352. 〔2〕Clinical and Laboratory Standards Institute,Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement〔杂〕. 2010,酝100-杂21. 〔3〕黄建生,张群智.临床感染标本的细菌谱及药敏分析〔J〕. 大理学院学报,2005,4(1):67-68. 〔4〕张群智,张红英,忍胜和,等. 产茁-内酰胺酶金黄色葡萄球 菌的耐楷性监测〔J〕.大理学院学报,2010,9(2):16-18. 〔5〕王健,方玲妹,李奕萍.尿路感染病原菌及其耐药性的调 查分析〔J〕.中华医院感染学杂志,2010,20(1):125-126. 〔6〕林菲菲,毛剑锋,金晶,等.尿路感染病原菌分布及大肠埃 希菌的耐药性变迁〔J〕.中华医院感染学杂志,2011,21 (24):5302-5304. 〔7〕张群智,周惠平.311株肠珠菌所致医院感染与耐药性分 析〔J〕.中华医院感染学杂志,2000,10(4):257. 〔8〕莫莉晓芳,张群智.大理学院附属医院大肠埃希菌和肺炎 克雷伯菌耐药性研究〔J〕.大理学院学报,2013,12(3): 59-62. 〔9〕管海宁,张群智.重症监护室非发酵菌的检出率及其耐药 性分析〔J〕.大理学院学报,2011,10(12):82-85. 〔10〕Jacoby GA,Archer G. New mechanisms of bacterial resistance to antimicrobial agents〔J〕. J Infect Dis,1991, 324(9):601-604. 〔11〕Pitout JD,Laupland KB. Extended-spectrum 茁-lactamaseproducing Enterobacteriaceae:an emerging public-health concern〔J〕. The Lancet infectious diseases,2008,8(3): 159-166. 〔12〕赵卫东,张群智.2009年附属医院产超广谱茁内酰胺酶大 肠埃希菌耐药性监测〔J〕.大理学院学报,2010,9(8): 58-60. 〔13〕刘素玲,王媚,何启勇,等. 大肠埃希菌表型分布及其耐药 性分析〔J〕.中国感染控制杂志,2009,8(2):94-97. 〔14〕刘朝晖,陈劲龙,叶惠芬,等. 克雷伯菌产超广谱茁-内酰胺 酶的检测及耐药性分析〔J〕.中华医院感染学杂志,2003, 13(4):375-377. 〔15〕Bush K. Alarming 茁-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae〔J〕. Current opinion in microbiology,2010,13(5):558-564. 〔16〕Jean SS,Hsueh PR. High burden of antimicrobial resistance in Asia〔J〕. International journal of antimicrobial agents,2011,37(4):291-295.